PML-RARA Regulated Adaptor Molecule 1 (PRAM1) (Middle Region) Peptid
PRAM1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle PRAM1 Produkte
- PRAM1 (PML-RARA Regulated Adaptor Molecule 1 (PRAM1))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- HFQDRQPEDI PQVPDEIYEL YDDVEPRDDS SPSPKGRDEA PSVQQAARRP
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- PRAM1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PRAM1 (PML-RARA Regulated Adaptor Molecule 1 (PRAM1))
- Synonyme
- PRAM1 Peptide, AY665714 Peptide, PML-RAR Peptide, PRAM-1 Peptide, RGD1564330 Peptide, PML-RARA regulated adaptor molecule 1 Peptide, PML-RAR alpha-regulated adaptor molecule 1 Peptide, PRAM1 Peptide, Pram1 Peptide
- Hintergrund
-
The protein encoded by this gene is similar to FYN binding protein (FYB/SLAP-130), an adaptor protein involved in T cell receptor mediated signaling. This gene is expressed and regulated during normal myelopoiesis. The expression of this gene is induced by retinoic acid and is inhibited by the expression of PML-RARalpha, a fusion protein of promyelocytic leukemia (PML) and the retinoic acid receptor-alpha (RARalpha).
Alias Symbols: PRAM-1, PML-RAR
Protein Size: 718 - Gen-ID
- 84106
- NCBI Accession
- NM_032152, NP_115528
- UniProt
- Q96QH2
-
Sie sind hier:
